BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 34524168)

  • 1. Dual-Time-Point 18F-Fluorocholine PET/CT Improves Characterization of Thyroid Nodules in Patients Referred for Primary Hyperparathyroidism: A Proof of Concept Study.
    Bani J; Morland D; Hubelé F; Ignat M; Latge A; Bourahla K; Zalzali M; Vix M; Taïeb D; Imperiale A
    Clin Nucl Med; 2021 Dec; 46(12):965-970. PubMed ID: 34524168
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Ciappuccini R; Licaj I; Lasne-Cardon A; Babin E; de Raucourt D; Blanchard D; Bastit V; Saguet-Rysanek V; Lequesne J; Peyronnet D; Grellard JM; Clarisse B; Bardet S
    Thyroid; 2021 May; 31(5):800-809. PubMed ID: 33183159
    [No Abstract]   [Full Text] [Related]  

  • 3. Dual-Time-Point 18 F-Fluorocholine PET/CT Improves Characterization of Thyroid Nodules in Patients Referred for Primary Hyperparathyroidism: A Proof of Concept Study: Reply.
    Imperiale A; Bani J; Taïeb D
    Clin Nucl Med; 2022 Oct; 47(10):e670-e671. PubMed ID: 35234194
    [No Abstract]   [Full Text] [Related]  

  • 4.
    Mathey C; Keyzer C; Blocklet D; Van Simaeys G; Trotta N; Lacroix S; Corvilain B; Goldman S; Moreno-Reyes R
    J Nucl Med; 2022 May; 63(5):785-791. PubMed ID: 34413141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re: Dual-Time-Point 18 F-Fluorocholine PET/CT Improves Characterization of Thyroid Nodules in Patients Referred for Primary Hyperparathyroidism: A Proof-of-Concept Study.
    Rueda MA; Bernal P; Ucros G
    Clin Nucl Med; 2022 Oct; 47(10):e670. PubMed ID: 35261356
    [No Abstract]   [Full Text] [Related]  

  • 6. 18F-Fluorocholine PET/CT and Parathyroid 4D Computed Tomography for Primary Hyperparathyroidism: The Challenge of Reoperative Patients.
    Amadou C; Bera G; Ezziane M; Chami L; Delbot T; Rouxel A; Leban M; Herve G; Menegaux F; Leenhardt L; Kas A; Trésallet C; Ghander C; Lussey-Lepoutre C
    World J Surg; 2019 May; 43(5):1232-1242. PubMed ID: 30659347
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Rizzo A; Racca M; Cauda S; Balma M; Dall'Armellina S; Dionisi B; Mossetti C; Bruna MC; Freddi M; Palestini N
    Endocrine; 2023 May; 80(2):433-440. PubMed ID: 36495390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Pilot Comparison of 18F-fluorocholine PET/CT, Ultrasonography and 123I/99mTc-sestaMIBI Dual-Phase Dual-Isotope Scintigraphy in the Preoperative Localization of Hyperfunctioning Parathyroid Glands in Primary or Secondary Hyperparathyroidism: Influence of Thyroid Anomalies.
    Michaud L; Balogova S; Burgess A; Ohnona J; Huchet V; Kerrou K; Lefèvre M; Tassart M; Montravers F; Périé S; Talbot JN
    Medicine (Baltimore); 2015 Oct; 94(41):e1701. PubMed ID: 26469908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The utility of 18F-fluorocholine PET/CT in the imaging of parathyroid adenomas.
    Mazurek A; Dziuk M; Witkowska-Patena E; Chudzinski W; Piszczek S; Gizewska A; Saracyn M
    Endokrynol Pol; 2022; 73(1):43-48. PubMed ID: 35119087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Effectiveness of Ultrasonography, 99mTc-Sestamibi, and 18F-Fluorocholine PET/CT in Detecting Parathyroid Adenomas in Patients With Primary Hyperparathyroidism.
    Thanseer N; Bhadada SK; Sood A; Mittal BR; Behera A; Gorla AKR; Kalathoorakathu RR; Singh P; Dahiya D; Saikia UN; Rao SD
    Clin Nucl Med; 2017 Dec; 42(12):e491-e497. PubMed ID: 28902729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of
    Piccardo A; Trimboli P; Puntoni M; Foppiani L; Treglia G; Naseri M; Bottoni GL; Massollo M; Sola S; Ferrarazzo G; Bruzzone M; Catrambone U; Arlandini A; Paone G; Ceriani L; Cabria M; Giovanella L
    Thyroid; 2019 Apr; 29(4):549-556. PubMed ID: 30864903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective evaluation of solitary thyroid nodule on 18F-FDG PET/CT and high-resolution ultrasonography.
    D'Souza MM; Marwaha RK; Sharma R; Jaimini A; Thomas S; Singh D; Jain M; Bhalla PJ; Tripathi M; Tiwari A; Mishra A; Mondal A; Tripathi RP
    Ann Nucl Med; 2010 Jun; 24(5):345-55. PubMed ID: 20373060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple endocrine neoplasia type 1 or 4: detection of hyperfunctioning parathyroid glands with 18F-fluorocholine PET/CT. Illustrative cases and pitfalls.
    Talbot JN; Zhang-Yin J; Kerrou K; Aveline C; Vagne B; Bélissant O; Tassart M; Périé S; Bouchard P; Christin-Maitre S; Ménégaux F; Groussin L; Gaujoux S; Balogová S; Montravers F
    Q J Nucl Med Mol Imaging; 2022 Jun; 66(2):130-140. PubMed ID: 35005879
    [No Abstract]   [Full Text] [Related]  

  • 14. Detectability of 18F-choline PET/MR in primary hyperparathyroidism.
    Araz M; Nak D; Soydal Ç; Peker E; Erden İ; Küçük NÖ
    Eur Arch Otorhinolaryngol; 2022 May; 279(5):2583-2589. PubMed ID: 34495350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is 18F-fluorocholine-positron emission tomography/computerized tomography a new imaging tool for detecting hyperfunctioning parathyroid glands in primary or secondary hyperparathyroidism?
    Michaud L; Burgess A; Huchet V; Lefèvre M; Tassart M; Ohnona J; Kerrou K; Balogova S; Talbot JN; Périé S
    J Clin Endocrinol Metab; 2014 Dec; 99(12):4531-6. PubMed ID: 25215560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic Performance of Cervical Ultrasound,
    Boudousq V; Guignard N; Gilly O; Chambert B; Mamou A; Moranne O; Zemmour M; Sharara H; Lallemant B
    J Nucl Med; 2022 Jul; 63(7):1081-1086. PubMed ID: 34857659
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Beheshti M; Hehenwarter L; Paymani Z; Rendl G; Imamovic L; Rettenbacher R; Tsybrovskyy O; Langsteger W; Pirich C
    Eur J Nucl Med Mol Imaging; 2018 Sep; 45(10):1762-1771. PubMed ID: 29516131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 18F-fluorocholine PET/CT and conventional imaging in primary hyperparathyroidism.
    Dudoignon D; Delbot T; Cottereau AS; Dechmi A; Bienvenu M; Koumakis E; Cormier C; Gaujoux S; Groussin L; Cochand-Priollet B; Clerc J; Wartski M
    Diagn Interv Imaging; 2022 May; 103(5):258-265. PubMed ID: 35039246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FCH-PET/CT in Primary Hyperparathyroidism With Discordant/Negative MIBI Scintigraphy and Ultrasonography.
    Koumakis E; Gauthé M; Martinino A; Sindayigaya R; Delbot T; Wartski M; Clerc J; Roux C; Borderie D; Cochand-Priollet B; Cormier C; Gaujoux S
    J Clin Endocrinol Metab; 2023 Jul; 108(8):1958-1967. PubMed ID: 36750257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of 4D computed tomography and F-18 fluorocholine PET for localisation of parathyroid lesions in primary hyperparathyroidism: A systematic review and meta-analysis.
    Patel DD; Bhattacharjee S; Pandey AK; Kopp CR; Ashwathanarayana AG; Patel HV; Barnabas R; Bhadada SK; Dodamani MH
    Clin Endocrinol (Oxf); 2023 Sep; 99(3):262-271. PubMed ID: 36593125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.